Alawi A Alsheikh-Ali

Summary

Affiliation: Massachusetts Institute of Technology
Country: USA

Publications

  1. doi Risk of arrhythmic and nonarrhythmic death in patients with heart failure and chronic kidney disease
    Alawi A Alsheikh-Ali
    Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, USA
    Am Heart J 161:204-209.e1. 2011
  2. ncbi Safety of lovastatin/extended release niacin compared with lovastatin alone, atorvastatin alone, pravastatin alone, and simvastatin alone (from the United States Food and Drug Administration adverse event reporting system)
    Alawi A Alsheikh-Ali
    Molecular Cardiology Research Institute and Division of Cardiology, Tufts New England Medical Center and Tufts University School of Medicine, Boston, Massachusetts, USA
    Am J Cardiol 99:379-81. 2007
  3. doi Baseline and on-treatment high-density lipoprotein cholesterol and the risk of cancer in randomized controlled trials of lipid-altering therapy
    Haseeb Jafri
    Molecular Cardiology Research Institute, Department of Medicine, Tufts Medical Center and Tufts University School of Medicine, Boston, Massachusetts 02111, USA
    J Am Coll Cardiol 55:2846-54. 2010
  4. ncbi Effect of the magnitude of lipid lowering on risk of elevated liver enzymes, rhabdomyolysis, and cancer: insights from large randomized statin trials
    Alawi A Alsheikh-Ali
    Molecular Cardiology Research Institute and Division of Cardiology, Department of Medicine, Tufts New England Medical Center and Tufts University School of Medicine, Boston, Massachusetts 02111, USA
    J Am Coll Cardiol 50:409-18. 2007
  5. doi 3D echocardiography to evaluate right atrial pressure in acutely decompensated heart failure correlation with invasive hemodynamics
    Ayan R Patel
    Cardiovascular Imaging and Hemodynamic Laboratory, Tufts Medical Center, Boston, Massachusetts 02111, USA
    JACC Cardiovasc Imaging 4:938-45. 2011
  6. doi Time-dependence of appropriate implantable defibrillator therapy in patients with ischemic cardiomyopathy
    Alawi A Alsheikh-Ali
    Institute for Clinical Research and Health Policy Studies, New England Cardiac Arrhythmia Center, Department of Medicine, Tufts New England Medical Center, Tufts University School of Medicine, Boston, Massachusetts 02111, USA
    J Cardiovasc Electrophysiol 19:784-9. 2008
  7. doi Reduced diameter spheres increases the risk of chest blow-induced ventricular fibrillation (commotio cordis)
    John Kalin
    Cardiac Arrhythmia Center, Division of Cardiology, Tufts Medical Center, Boston, Massachusetts, USA
    Heart Rhythm 8:1578-81. 2011
  8. doi Pre-operative left atrial mechanical function predicts risk of atrial fibrillation following cardiac surgery
    Jessica A Haffajee
    Cardiovascular Imaging and Hemodynamic Laboratory, Tufts Medical Center, Boston, Massachusetts 02111, USA
    JACC Cardiovasc Imaging 4:833-40. 2011
  9. doi Marked variability in susceptibility to ventricular fibrillation in an experimental commotio cordis model
    Alawi A Alsheikh-Ali
    Cardiac Arrhythmia Center, Division of Cardiology, Tufts Medical Center, 800 Washington St, Box 197, Boston, MA 02111, USA
    Circulation 122:2499-504. 2010
  10. ncbi Relative safety of gemfibrozil and fenofibrate in the absence of concomitant cerivastatin use
    Noa Holoshitz
    Molecular Cardiology Research Institute and Division of Cardiology, Department of Medicine, Tufts New England Medical Center and Tufts University School of Medicine, Boston, Massachusetts, USA
    Am J Cardiol 101:95-7. 2008

Collaborators

Detail Information

Publications22

  1. doi Risk of arrhythmic and nonarrhythmic death in patients with heart failure and chronic kidney disease
    Alawi A Alsheikh-Ali
    Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, USA
    Am Heart J 161:204-209.e1. 2011
    ....
  2. ncbi Safety of lovastatin/extended release niacin compared with lovastatin alone, atorvastatin alone, pravastatin alone, and simvastatin alone (from the United States Food and Drug Administration adverse event reporting system)
    Alawi A Alsheikh-Ali
    Molecular Cardiology Research Institute and Division of Cardiology, Tufts New England Medical Center and Tufts University School of Medicine, Boston, Massachusetts, USA
    Am J Cardiol 99:379-81. 2007
    ....
  3. doi Baseline and on-treatment high-density lipoprotein cholesterol and the risk of cancer in randomized controlled trials of lipid-altering therapy
    Haseeb Jafri
    Molecular Cardiology Research Institute, Department of Medicine, Tufts Medical Center and Tufts University School of Medicine, Boston, Massachusetts 02111, USA
    J Am Coll Cardiol 55:2846-54. 2010
    ..We sought to examine the relationship between high-density lipoprotein cholesterol (HDL-C) levels and the risk of the development of cancer in large randomized controlled trials (RCTs) of lipid-altering interventions...
  4. ncbi Effect of the magnitude of lipid lowering on risk of elevated liver enzymes, rhabdomyolysis, and cancer: insights from large randomized statin trials
    Alawi A Alsheikh-Ali
    Molecular Cardiology Research Institute and Division of Cardiology, Department of Medicine, Tufts New England Medical Center and Tufts University School of Medicine, Boston, Massachusetts 02111, USA
    J Am Coll Cardiol 50:409-18. 2007
    ..We sought to assess the relationship between the magnitude of low-density lipoprotein cholesterol (LDL-C) lowering and rates of elevated liver enzymes, rhabdomyolysis, and cancer...
  5. doi 3D echocardiography to evaluate right atrial pressure in acutely decompensated heart failure correlation with invasive hemodynamics
    Ayan R Patel
    Cardiovascular Imaging and Hemodynamic Laboratory, Tufts Medical Center, Boston, Massachusetts 02111, USA
    JACC Cardiovasc Imaging 4:938-45. 2011
    ....
  6. doi Time-dependence of appropriate implantable defibrillator therapy in patients with ischemic cardiomyopathy
    Alawi A Alsheikh-Ali
    Institute for Clinical Research and Health Policy Studies, New England Cardiac Arrhythmia Center, Department of Medicine, Tufts New England Medical Center, Tufts University School of Medicine, Boston, Massachusetts 02111, USA
    J Cardiovasc Electrophysiol 19:784-9. 2008
    ..We assessed the incidence and time-dependence of appropriate ICD therapy in a routine clinical practice primary prevention population with prior myocardial infarction (MI) and reduced left ventricular ejection fraction (LVEF)...
  7. doi Reduced diameter spheres increases the risk of chest blow-induced ventricular fibrillation (commotio cordis)
    John Kalin
    Cardiac Arrhythmia Center, Division of Cardiology, Tufts Medical Center, Boston, Massachusetts, USA
    Heart Rhythm 8:1578-81. 2011
    ..However, the risk of ventricular fibrillation (VF) relative to the shape of the impact object is not known...
  8. doi Pre-operative left atrial mechanical function predicts risk of atrial fibrillation following cardiac surgery
    Jessica A Haffajee
    Cardiovascular Imaging and Hemodynamic Laboratory, Tufts Medical Center, Boston, Massachusetts 02111, USA
    JACC Cardiovasc Imaging 4:833-40. 2011
    ....
  9. doi Marked variability in susceptibility to ventricular fibrillation in an experimental commotio cordis model
    Alawi A Alsheikh-Ali
    Cardiac Arrhythmia Center, Division of Cardiology, Tufts Medical Center, 800 Washington St, Box 197, Boston, MA 02111, USA
    Circulation 122:2499-504. 2010
    ..Using our model of commotio cordis, we evaluated individual animal susceptibility to VF induction and assessed animal characteristics that might be involved...
  10. ncbi Relative safety of gemfibrozil and fenofibrate in the absence of concomitant cerivastatin use
    Noa Holoshitz
    Molecular Cardiology Research Institute and Division of Cardiology, Department of Medicine, Tufts New England Medical Center and Tufts University School of Medicine, Boston, Massachusetts, USA
    Am J Cardiol 101:95-7. 2008
    ..Rates of all AERs and serious AERs were higher with fenofibrate, but well within the range observed with commonly used lipid-altering medications...
  11. doi Heart failure in patients hospitalized with acute coronary syndromes: observations from the Gulf Registry of Acute Coronary Events (Gulf RACE)
    Alawi A Alsheikh-Ali
    Division of Cardiology, Institute of Cardiac Sciences, Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates
    Eur J Heart Fail 11:1135-42. 2009
    ..We describe the prevalence and prognostic significance of heart failure (HF) complicating acute coronary syndromes (ACS) in patients enrolled in the Gulf Registry of Acute Coronary Events (Gulf RACE)...
  12. ncbi Prevalence of low high-density lipoprotein cholesterol in patients with documented coronary heart disease or risk equivalent and controlled low-density lipoprotein cholesterol
    Alawi A Alsheikh-Ali
    Division of Cardiology and Molecular Cardiology Research Institute, Department of Medicine, Tufts New England Medical Center and Tufts University School of Medicine, Boston, Massachusetts, USA
    Am J Cardiol 100:1499-501. 2007
    ..In conclusion, in high-risk patients with CHD or CHD risk equivalents, low HDL cholesterol levels remain prevalent despite statin treatment and the achievement of aggressive LDL cholesterol goals...
  13. ncbi Assessment of peripheral vascular endothelial function in the ambulatory setting
    Jeffrey T Kuvin
    Department of Medicine Division of Cardiology, Tufts New England Medical Center, Boston, Massachusetts 02111, USA
    Vasc Med 12:13-6. 2007
    ..In conclusion, these data suggest that peripheral vascular endothelial function testing is feasible in ambulatory patients, and this is an important next step in bringing this technology to clinical applicability...
  14. doi Precordial thump for cardiac arrest is effective for asystole but not for ventricular fibrillation
    Christopher Madias
    Cardiac Arrhythmia Center, Division of Cardiology, Tufts Medical Center, Boston, MA 02111, USA
    Heart Rhythm 6:1495-500. 2009
    ..e., commotio cordis), they paradoxically have been regarded as potential therapy for cardiac arrest. In commotio cordis, impact energy and resultant peak left ventricular (LV) pressure are important variables in VF initiation...
  15. pmc Percutaneous coronary interventions for non-acute coronary artery disease: a quantitative 20-year synopsis and a network meta-analysis
    Thomas A Trikalinos
    Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, USA
    Lancet 373:911-8. 2009
    ..We undertook a systematic overview of randomised trials comparing these interventions with each other and with medical therapy in patients with non-acute coronary artery disease...
  16. doi The vulnerable atherosclerotic plaque: scope of the literature
    Alawi A Alsheikh-Ali
    Institute for Clinical Research and Health Policy Studies, Tufts University School of Medicine, Boston, MA, USA
    Ann Intern Med 153:387-95. 2010
    ..Large prospective studies in patients with and without previous cardiovascular events during long follow-up are required to validate this concept...
  17. doi Statins, low-density lipoprotein cholesterol, and risk of cancer
    Alawi A Alsheikh-Ali
    Institute for Clinical Research and Health Policy Studies, Department of Medicine, Tufts Medical Center and Tufts University School of Medicine, Boston, Massachusetts 02111, USA
    J Am Coll Cardiol 52:1141-7. 2008
    ..We sought to assess whether statin-mediated reductions in low-density lipoprotein cholesterol (LDL-C) are associated with an increased risk of cancer...
  18. doi The safety of niacin in the US Food and Drug Administration adverse event reporting database
    Alawi A Alsheikh-Ali
    Institute for Clinical Research and Health Policy Studies and Molecular Cardiology Research Institute, Department of Medicine, Tufts New England Medical Center and Tufts University School of Medicine, Boston, Massachusetts 02111, USA
    Am J Cardiol 101:9B-13B. 2008
    ..These analyses should encourage the use of niacin-ER in patients at high risk for cardiovascular disease, as recommended by current national guidelines for cardiovascular prevention...
  19. pmc Association of prolonged QRS duration with ventricular tachyarrhythmias and sudden cardiac death in the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II)
    Ritesh Dhar
    Institute for Clinical Research and Health Policy Studies, Department of Medicine, Tufts Medical Center, Tufts University School of Medicine, Boston, Massachusetts, USA
    Heart Rhythm 5:807-13. 2008
    ..There is conflicting literature on the relationship between prolonged QRS duration (QRSd) and arrhythmic events, including sudden cardiac death (SCD), in heart failure patients with or without implantable cardioverter-defibrillators (ICDs)...
  20. ncbi Ezetimibe, and the combination of ezetimibe/simvastatin, and risk of cancer: A post-marketing analysis
    Alawi A Alsheikh-Ali
    Institute for Clinical Research and Health Policy Studies, Tufts Medical Center and Tufts University School of Medicine, 800 Washington St, Box 80, Boston, MA 02111USA Molecular Cardiology Research Institute, Department of Medicine, Tufts Medical Center and Tufts University School of Medicine, 800 Washington St, Boston, MA 02111USA
    J Clin Lipidol 3:138-42. 2009
    ....
  21. doi Meta-analysis: statin therapy does not alter the association between low levels of high-density lipoprotein cholesterol and increased cardiovascular risk
    Haseeb Jafri
    Molecular Cardiology Research Institute, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, and Tufts University School of Medicine, Boston, Massachusetts 02111, USA
    Ann Intern Med 153:800-8. 2010
    ..Low levels of high-density lipoprotein cholesterol (HDL-C) are associated with an increased risk for myocardial infarction (MI). Although statins reduce the risk for MI, most cardiovascular events still occur despite statin treatment...
  22. doi Predictors of atrial fibrillation recurrence after radiofrequency catheter ablation: a systematic review
    Ethan M Balk
    Tufts Evidence based Practice Center, TuftsMedical Center, Boston, Massachusetts, USA
    J Cardiovasc Electrophysiol 21:1208-16. 2010
    ..AF Recurrence After RFA: Systematic Review...